LEPU ScienTech repurchases 81,000 H-shares; cumulative buyback reaches 2.02 million shares under 2026 mandate

Bulletin Express

Jul 20

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (abbrev. “LEPU ScienTech”) disclosed that it bought back 81,000 H-shares on 20 July 2026 through on-market transactions at prices between HKD 11.16 and HKD 11.23, for a total consideration of HKD 0.91 million.

Including this latest tranche, the company has repurchased 2.02 million shares between 26 June and 20 July 2026. The cumulative buybacks represent 0.58% of the 346.75 million issued shares outstanding on 22 May 2026—the date on which shareholders approved the current repurchase mandate authorising up to 34.67 million shares.

All 2.02 million repurchased shares are intended for cancellation and remain to be cancelled as of 20 July 2026. Following the latest transactions, LEPU ScienTech’s issued share capital stands unchanged at 346.75 million shares, with no treasury shares held.

Under Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 19 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1169782246"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169782246\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169782246?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-20 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169782246","market":"us","top_or_hot":-1,"title":"LEPU ScienTech repurchases 81,000 H-shares; cumulative buyback reaches 2.02 million shares under 2026 mandate","media":"Bulletin Express","content":"<p>LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (abbrev. “LEPU ScienTech”) disclosed that it bought back 81,000 H-shares on 20 July 2026 through on-market transactions at prices between HKD 11.16 and HKD 11.23, for a total consideration of HKD 0.91 million.</p>\n<p>Including this latest tranche, the company has repurchased 2.02 million shares between 26 June and 20 July 2026. The cumulative buybacks represent 0.58% of the 346.75 million issued shares outstanding on 22 May 2026—the date on which shareholders approved the current repurchase mandate authorising up to 34.67 million shares.</p>\n<p>All 2.02 million repurchased shares are intended for cancellation and remain to be cancelled as of 20 July 2026. Following the latest transactions, LEPU ScienTech’s issued share capital stands unchanged at 346.75 million shares, with no treasury shares held.</p>\n<p>Under Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 19 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU ScienTech repurchases 81,000 H-shares; cumulative buyback reaches 2.02 million shares under 2026 mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU ScienTech repurchases 81,000 H-shares; cumulative buyback reaches 2.02 million shares under 2026 mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-20 18:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (abbrev. “LEPU ScienTech”) disclosed that it bought back 81,000 H-shares on 20 July 2026 through on-market transactions at prices between HKD 11.16 and HKD 11.23, for a total consideration of HKD 0.91 million.</p>\n<p>Including this latest tranche, the company has repurchased 2.02 million shares between 26 June and 20 July 2026. The cumulative buybacks represent 0.58% of the 346.75 million issued shares outstanding on 22 May 2026—the date on which shareholders approved the current repurchase mandate authorising up to 34.67 million shares.</p>\n<p>All 2.02 million repurchased shares are intended for cancellation and remain to be cancelled as of 20 July 2026. Following the latest transactions, LEPU ScienTech’s issued share capital stands unchanged at 346.75 million shares, with no treasury shares held.</p>\n<p>Under Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 19 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02291","symbol_name":"心泰医疗","start_time":0,"source_url":"","article_id":"1169782246","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169782246","pubTimestamp":1784544245,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (abbrev. “LEPU ScienTech”) disclosed that it bought back 81,000 H-shares on 20 July 2026 through on-market transactions at prices between HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02291":"心泰医疗"},"translate_title":"乐普科技回购8.1万股H股；2026 年授权累计回购达到 202 万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02291":1},"content_text":"LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (abbrev. “LEPU ScienTech”) disclosed that it bought back 81,000 H-shares on 20 July 2026 through on-market transactions at prices between HKD 11.16 and HKD 11.23, for a total consideration of HKD 0.91 million.\nIncluding this latest tranche, the company has repurchased 2.02 million shares between 26 June and 20 July 2026. The cumulative buybacks represent 0.58% of the 346.75 million issued shares outstanding on 22 May 2026—the date on which shareholders approved the current repurchase mandate authorising up to 34.67 million shares.\nAll 2.02 million repurchased shares are intended for cancellation and remain to be cancelled as of 20 July 2026. Following the latest transactions, LEPU ScienTech’s issued share capital stands unchanged at 346.75 million shares, with no treasury shares held.\nUnder Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 19 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}